Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.
Article
CAS
Google Scholar
Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg. 2002;236:397–406.
Article
Google Scholar
Poon RT, Fan ST, Lo CM, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004;240:698–708.
PubMed
PubMed Central
Google Scholar
Marcucci C, Madjdpour C, Spahn DR. Allogeneic blood transfusions: benefit, risks and clinical indications in countries with a low or high human development index. Br Med Bull. 2004;70:15–28.
Article
Google Scholar
Tomimaru Y, Wada H, Marubashi S, et al. Fresh frozen plasma transfusion does not affect outcomes following hepatic resection for hepatocellular carcinoma. World J Gastroenterol. 2010;16:5603–10.
Article
Google Scholar
Harada N, Shirabe K, Maeda T, et al. Blood transfusion is associated with recurrence of hepatocellular carcinoma after hepatectomy in child–Pugh class a patients. World J Surg. 2015;39:1044–51.
Article
Google Scholar
Wada H, Eguchi H, Nagano H, et al. Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis. Surg Today. 2018;48:73–9.
Article
Google Scholar
Kuroda S, Tashiro H, Kobayashi T, et al. No impact of perioperative blood transfusion on recurrence of hepatocellular carcinoma after hepatectomy. World J Surg. 2012;36:651–8.
Article
Google Scholar
Yang T, Lu J-H, Lau WY, et al. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: a propensity score matching analysis. J Hepatol. 2016;64:583–93.
Article
Google Scholar
Honmyo N, Kobayashi T, Hamaoka M, et al. Comparison of new prognostic systems for patients with resectable hepatocellular carcinoma: albumin-bilirubin grade and albumin-indocyanine green evaluation grade. Hepatol Res. 2019;49:1218-26.
Horino K, Beppu T, Kuroki H, et al. Glasgow prognostic score as a useful prognostic factor after hepatectomy for hepatocellular carcinoma. Int J Clin Oncol. 2013;18:829–38.
Article
Google Scholar
Harimoto N, Yoshizumi T, Shimagaki T, et al. Inflammation-based prognostic score in patients with living donor liver transplantation for hepatocellular carcinoma. Anticancer Res. 2016;36:5537–42.
Article
Google Scholar
Abe T, Tashiro H, Kobayashi T, et al. Glasgow prognostic score and prognosis after hepatectomy for hepatocellular carcinoma. World J Surg. 2017;41:1860–70.
Article
Google Scholar
Abe T, Amano H, Kobayashi T, et al. Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma. Eur J Surg Oncol. 2018;44:1573–9.
Article
Google Scholar
Voron T, Tselikas L, Pietrasz D, et al. Sarcopenia impacts on short-and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg. 2015;261:1173–83.
Article
Google Scholar
Kamachi S, Mizuta T, Otsuka T, et al. Sarcopenia is a risk factor for the recurrence of hepatocellular carcinoma after curative treatment. Hepat Res. 2016;46:201–8.
Article
CAS
Google Scholar
Harimoto N, Shirabe K, Yamashita YI, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg. 2013;100:1523–30.
Article
CAS
Google Scholar
Morimoto O, Nagano H, Sakon M, et al. Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas. J Hepatol. 2003;39:215–21.
Article
CAS
Google Scholar
Hao S, Fan P, Chen S, et al. Distinct recurrence risk factors for intrahepatic metastasis and multicenter occurrence after surgery in patients with hepatocellular carcinoma. J Gastrointest Surg. 2017;21:312–20.
Article
Google Scholar
Kim JM, Kwon C, Joh J-W, et al. Intrahepatic metastasis is more risky than multiple occurrence in hepatocellular carcinoma patients after curative liver resection. Hepato-gastroenterology. 2015;62:399–404.
CAS
PubMed
Google Scholar
Tsai T-J, Chau G-Y, Lui W-Y, et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery. 2000;127:603–8.
Article
CAS
Google Scholar
Esnaola NF, Lauwers GY, Mirza NQ, et al. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg. 2002;6:224–32.
Article
Google Scholar
Mitsiopoulos N, Baumgartner R, Heymsfield S, et al. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol. 1998;85:115–22.
Article
CAS
Google Scholar
Dodson RM, Firoozmand A, Hyder O, et al. Impact of sarcopenia on outcomes following intra-arterial therapy of hepatic malignancies. J Gastrointest Surg. 2013;17:2123–32.
Article
Google Scholar
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010;39:412–23.
Article
Google Scholar
Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the international sarcopenia initiative (EWGSOP and IWGS). Age Ageing. 2014;43:748–59.
Article
Google Scholar
Valenzuela T. Efficacy of progressive resistance training interventions in older adults in nursing homes: a systematic review. J Am Med Dir Assoc. 2012;13:418–4128.
Article
Google Scholar
Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012;8:457.
Article
CAS
Google Scholar
Tessari P. Protein metabolism in liver cirrhosis: from albumin to muscle myofibrils. Curr Opin Clin Nutr Metab Care. 2003;6:79–85.
Article
CAS
Google Scholar
Dasarathy S. Consilience in sarcopenia of cirrhosis. J Cachexia Sarcopenia Muscle. 2012;3:225–37.
Article
Google Scholar
Kaido T, Ogawa K, Fujimoto Y, et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J of Transplant. 2013;13:1549–56.
Article
CAS
Google Scholar
Asahara T, Katayama K, Itamoto T, et al. Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg. 1999;23:676–80.
Article
CAS
Google Scholar
Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood. 2001;97:1180–95.
Article
CAS
Google Scholar
Sugita S, Sasaki A, Iwaki K, et al. Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intraoperative allogenic blood transfusion: a retrospective study. Eur J Surg Oncol (EJSO). 2008;34:339–45.
Article
CAS
Google Scholar
Kwon AH, Matsui Y, Kamiyama Y. Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival. Cancer. 2001;91:771–8.
Article
CAS
Google Scholar
Itasaka H, Yamamoto K, Taketomi A, et al. Influence of blood transfusion on postoperative long-term liver function in patients with hepatocellular carcinoma. Hepatogastroenterology. 1995;42:465–8.
CAS
PubMed
Google Scholar
Lopez-Aguiar AG, Ethun CG, Pawlik TM, et al. Association of perioperative transfusion with recurrence and survival after resection of distal cholangiocarcinoma: a 10-institution study from the US extrahepatic biliary malignancy consortium. Ann Surg Oncol. 2019;26:1814–23.
Article
Google Scholar
Park HM, Park SJ, Shim JR, et al. Perioperative transfusion in pancreatoduodenectomy: the double-edged sword of pancreatic surgeons. Medicine (Baltimore). 2017;96:e9019.
Article
Google Scholar